Use of Lactobacillus for treatment of autoimmune diseases
AssigneeProbi AB
InventorsJan Alenfall, Anna Berggren, Carola Rask, Agnes Wold, Shahram Aghaibeik-Lavasani
Life of this patent
Estimating the term…
Abstract
The present technology relates to the use of at least one strain of probiotic bacteria selected from Lactobacillus for the manufacture of a medicament for the treatment and/or prevention of an autoimmune disease.
Claims5
A method of treating multiple sclerosis comprising administering to an individual having multiple sclerosis a sufficient amount of at least one isolated strain of probiotic Lactobacillus selected from the group consisting of Lactobacillus plantarum HEAL 9 deposited as DSM 15312, Lactobacillus plantarum HEAL 19 deposited as DSM 15313, and Lactobacillus paracasei 8700:2 deposited as DSM 13434.
A method of treating multiple sclerosis comprising administering to an individual having multiple sclerosis a sufficient amount of a combination of isolated strains of probiotic Lactobacillus plantarum HEAL 9 deposited as DSM 15312, Lactobacillus plantarum HEAL 19 deposited as DSM 15313, and Lactobacillus paracasei 8700:2 deposited as DSM 13434.
Dependencies are inferred from the claim text.